LLY 818.22 (+1.61%)
US5324571083Drug ManufacturersDrug Manufacturers - General

Eli Lilly (LLY) Stock Highlights

818.22 | +1.61%
2025-04-02 22:11:10
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lillys key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Read more...

Statistics

Range Today
795.04 819.84
Volume Today 2.68M
Range 1 Year
711.4 972.53
Volume 1 Year 831.62M
Range 3 Year
276.83 972.53
Volume 3 Year 2.34B
Range 10 Year
64.18 972.53
Volume 10 Year 10.32B

Highlights

Market Capitalization 738.61B (mega)
Floating Shares 895.94M
Current Price 818.22
Price To Earnings 69.79
Price To Revenue 17.1
Price To Book 52.02
Earnings Per Share 11.75
Dividend Yield 0.73%
Dividend Per Share 6
Payout Ratio 44.41%

Performance

Latest +1.61%
1 Month -10.36%
3 Months +4.82%
6 Months -7.02%
1 Year +8.36%
3 Years +179.49%
5 Years +504.52%
10 Years +1045%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.